Patient Perspectives on a Decision Aid for Systemic Lupus Erythematosus: Insights and Future Considerations

J Rheumatol. 2024 Jun 1:jrheum.2023-1178. doi: 10.3899/jrheum.2023-1178. Online ahead of print.

Abstract

Objective: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide spectrum of clinical manifestations. A decision aid (DA) for SLE was developed and implemented in 15 rheumatology clinics throughout the United States. This study explored the experiences of patients who viewed the DA to understand how patients engage with and respond to the SLE DA.

Methods: We conducted a qualitative descriptive study using semistructured interviews with a convenience sample of 24 patients during May to July 2022.

Results: Patients recognized the value of the SLE DA in providing general knowledge about SLE and different treatment options. However, patients expressed a desire for more comprehensive lifestyle information to better manage their condition. Another theme was the importance of having multiple formats available to cater to their different needs, as well as tailoring the DA to different stages of SLE.

Conclusion: This study contributes to a broader understanding of how to provide patient-centered care for patients with SLE by offering practical insights that can inform the development of more effective, patient-centric health information technologies for managing chronic diseases, ultimately improving patient outcomes. Overall, this study underscores the significance of optimizing both the information content and determining the appropriate delivery of the tool for its future sustainability.